NVO's shares are down 2% despite making Wegovy available at a discounted price of $499 per month at local pharmacies.

Novo Nordisk said on Monday all eligible cash-paying customers in the United States can buy its weight-loss drug Wegovy at a ...

Novo Nordisk has quickly expanded its discounted Wegovy program, now offering all eligible cash-paying customers its popular ...

Novo Nordisk’s Wegovy is about to enter the Irish market but people will have to pay for it from their own pocket - for now ...

Novo Nordisk has updated its Wegovy savings program, allowing eligible cash-paying patients to access the drug at retail ...

Collective Health, a leader in employee health benefits, and digital healthcare leader Noom 's enterprise division, Noom Health, have partnered to deliver Collective Health + Noom Med with Smart Rx, ...

Patients with commercial insurance that does not cover ... innovative medicines and making them accessible and affordable. Wegovy® is an FDA-approved semaglutide injection prescribed alongside ...

While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...

The updated savings program aims to make Wegovy® more accessible to individuals managing obesity, offering a 28-day supply at a lower price than the previous $650 per month. Patients with commercial ...

With crucial lessons learned from the manufacturing shortages of injectable GLP-1s, experts say securing adequate supply for ...